NAD+ — 500mg
Nicotinamide Adenine Dinucleotide (NAD+) is an essential coenzyme found in every living cell, playing a central role in cellular energy metabolism and over 500 enzymatic reactions. This research-grade formulation is intended for in-vitro and preclinical research applications investigating NAD+ biology.
Satisfaction Guarantee: If your order arrives damaged or does not match the certified specification, we will replace it. No questions asked.
Specifications
- Compound
- Nicotinamide Adenine Dinucleotide (oxidized form)
- Molecular Weight
- 663.43 Da
- Quantity
- 500mg per vial
- Purity
- ≥98% (HPLC verified)
- Form
- Lyophilized powder
- Appearance
- White to yellow powder
- Storage
- -20°C recommended
Certificate of Analysis
This product is supplied with a third-party certificate of analysis. Documentation is available upon request — contact us with your order number and we will provide it within 24 hours.
Request COAResearch Applications
NAD+ biology is one of the most active areas of aging and longevity research. Published studies investigate its role in sirtuin activation (SIRT1-7), PARP-mediated DNA repair, circadian rhythm regulation, and mitochondrial function. Research by David Sinclair (Harvard), Eric Verdin (Buck Institute), and others has established NAD+ decline as a hallmark of aging in preclinical models. Research applications include cell culture supplementation, enzymatic assays, and metabolic pathway studies.
Key Published Research
- Yoshino et al., Cell Metabolism 2018 — NAD+ intermediates in aging research
- Rajman et al., Cell Metabolism 2018 — Comprehensive NAD+ research review
Storage & Handling
Store lyophilized powder at -20°C in a dark, dry environment. NAD+ is hygroscopic and light-sensitive. Once reconstituted, store at 2-8°C, protect from light, and use within 14 days.
Other Compounds Researchers Also Order
Customer Feedback
“NAD+ came with clear documentation and was exactly as described. This is my go-to source now. Trustworthy and professional — rare combo in this industry.”
Lisa P.